Reszon ABC Combo Test – Flu A+B & COVID-19 Ag (Nasal Swab)

Reszon ABC Combo Test – Flu A+B & COVID-19 Ag (Nasal Swab)

MDA Registration number:

Reszon ABC Combo Test – FLU A+B & COVID-19 Ag (Nasal Swab) is an immunochromatographic assay designed for the in vitro qualitative detection and differentiation of influenza A, B and/or SARS-CoV-2 nucleocapsid antigen in direct anterior nasal swab specimens from individuals suspected of respiratory viral infection consistent with Influenza or COVID-19 within the first seven days of symptom onset. The results obtained should not be the sole determinant for clinical decision. The test is intended for professional in vitro diagnostic use.

Platform Immunochromatographic Assay
Format Cassette
Detection Influenza A, B and/or SARS-CoV-2 nucleocapsid antigen
Specimen Direct anterior nasal swab
Sensitivity 91.25% (Influenza A)

92.05% (Influenza B)

96.05% (COVID-19)

Specificity 100% (Influenza A, Influenza B and COVID-19)
Assay Time 20 minutes
Shelf Life* 24 months

*From date of manufacture

 

Cat. No.

Product Description

Test Specimen

Product Format

Intended Use

Intended Use

Storage Temp.

Packing Size

RCV-RD00301-01

Reszon ABC Combo Test – Flu A+B & COVID-19 Ag
(Nasal Swab)

Nasal swab

Cassette

Influenza A, B and/or SARS-CoV-2 nucleocapsid antigen

For Professional Use

4-30°C

1 T/ Kit

RCV-RD00301-10

Reszon ABC Combo Test – Flu A+B & COVID-19 Ag
(Nasal Swab)

Nasal swab

Cassette

Influenza A, B and/or SARS-CoV-2 nucleocapsid antigen

For Professional Use

4-30°C

10 T/ Kit

RCV-RD00301-25

Reszon ABC Combo Test – Flu A+B & COVID-19 Ag
(Nasal Swab)

Nasal swab

Cassette

Influenza A, B and/or SARS-CoV-2 nucleocapsid antigen

For Professional Use

4-30°C

25 T/ Kit